211 related articles for article (PubMed ID: 12969829)
1. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis.
Totsuka T; Kanai T; Uraushihara K; Iiyama R; Yamazaki M; Akiba H; Yagita H; Okumura K; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G595-603. PubMed ID: 12631559
[TBL] [Abstract][Full Text] [Related]
3. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
[TBL] [Abstract][Full Text] [Related]
4. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
[TBL] [Abstract][Full Text] [Related]
5. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
6. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
7. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
8. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.
Aranda R; Sydora BC; McAllister PL; Binder SW; Yang HY; Targan SR; Kronenberg M
J Immunol; 1997 Apr; 158(7):3464-73. PubMed ID: 9120308
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
[TBL] [Abstract][Full Text] [Related]
10. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
11. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice.
Dohi T; Fujihashi K; Koga T; Shirai Y; Kawamura YI; Ejima C; Kato R; Saitoh K; McGhee JR
Gastroenterology; 2003 Mar; 124(3):672-82. PubMed ID: 12612906
[TBL] [Abstract][Full Text] [Related]
12. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
13. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
[TBL] [Abstract][Full Text] [Related]
14. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
16. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
Miura N; Yamamoto M; Fukutake M; Ohtake N; Iizuka S; Ishige A; Sasaki H; Fukuda K; Yamamoto T; Hayakawa S
Int Immunol; 2005 May; 17(5):513-22. PubMed ID: 15778290
[TBL] [Abstract][Full Text] [Related]
18. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
[TBL] [Abstract][Full Text] [Related]
19. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
20. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis.
Fort MM; Leach MW; Rennick DM
J Immunol; 1998 Oct; 161(7):3256-61. PubMed ID: 9759840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]